This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated SMURF2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SMURF2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~86.2 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Testis (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A02585 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | C2C12 cell lysate (catalog A02585) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02585 · 1 μg/ml (catalog A02585) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SMURF2 is predicted at 86.2 kDa; no empirical band is supplied, and its listed features do not demonstrate a migration shift.
| Single band near 86.2 kDa in whole-cell lysate | Consistent with predicted full-length SMURF2; confirm identity with controls |
| Band near 86.2 kDa in a nuclear fraction | Consistent with SMURF2's reported nuclear location |
| Band near 86.2 kDa in a cytoplasmic fraction | Consistent with SMURF2's reported cytoplasmic location |
| Band near 86.2 kDa in a membrane fraction | Consistent with SMURF2's reported membrane location |
| Predicted full-length mass | Sets 86.2 kDa as the sequence-based reference, not a measured band position |
| Predicted mass in whole-cell lysate | Provides an 86.2 kDa reference for a candidate full-length band |
| Predicted mass in nuclear and cytoplasmic fractions | Provides the same 86.2 kDa reference in either fraction |
| Predicted mass in membrane fractions | Provides the same 86.2 kDa reference in this reported location |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | SMURF2 signal may be below detection or lost during extraction | Check antibody performance with a positive-control lysate |
| Band higher than expected | Identity or migration of the band is unverified | Compare with a positive control and test whether SMURF2 depletion removes it |
| Band lower than expected | Protein integrity or band identity is unverified | Use fresh lysate with protease inhibitors and test SMURF2 depletion |
| Multiple bands | Specificity of additional bands is unverified | Compare the bands before and after SMURF2 depletion |
| Weak or no signal | Abundance or extraction may be insufficient | Check loading and examine nuclear, cytoplasmic, and membrane fractions |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | spermatogonia cells | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Medium | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | Medium | Protein (IHC) | HPA → |
| Duodenum | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Not detected | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SMURF2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Four the supplier anti-SMURF2 antibodies list Human, Mouse, and Rat reactivity and have WB images. Captions document specific tested lysates; A02585-1 and RP1102 report bands near the expected 86 kDa. These examples do not establish performance in every sample type.
Which to pick: Choose A02585-1 for the most detailed pictured examples across human cell, rat tissue, and mouse tissue lysates. A02585 shows C2C12 lysate, M02585 shows SH-SY-5Y lysate, and RP1102 shows SMMC lysate. Match your sample and conditions to the closest documented example.